首页> 外文期刊>Frontiers in Microbiology >Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China
【24h】

Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern China

机译:中国东部耐碳青霉烯类肺炎克雷伯菌感染的分子流行病学及危险因素

获取原文
           

摘要

Background: The increasing prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses an immediate threat to treatment worldwide. This retrospective study assessed the molecular epidemiology and determined the risk factors for and outcomes of CRKP infections in a general teaching hospital in Shanghai, China. Methods: From January 2013 to July 2015, 100 consecutive unique CRKP isolates isolated from hospitalized patients were collected. Isolates were screened for antibiotic resistance genes by polymerase chain reaction and molecular typing was performed by pulsed-field gel electrophoresis (PFGE). Patients infected with CRKP comprised the case group and were compared to the control group of patients infected with carbapenem-susceptible Klebsiella pneumoniae . Therapeutic effects were compared in the CRKP infection group. Results: Among the 100 CRKP isolates, the percentages of multidrug-resistant, extensively drug-resistant (XDR), and pandrug-resistant were 50.0, 50.0, and 0%, respectively. All the CRKP isolates produced KPC-2 and could be divided into 18 PFGE clusters (A–O) and 70 subtypes. No dominant intra-hospital PFGE type was detected using a cutoff of 80% similarity. The ratio of CRKP infection to colonization was 51 to 49. Risk factors correlated with CRKP infection included pulmonary disease ( p = 0.038), ICU stay ( p = 0.002), invasive ventilation ( p = 0.009), blood transfusion ( p = 0.028), parenteral nutrition ( p = 0.004), sputum suction ( p = 0.006), medical history of previous hospitalization ( p = 0.022), exposure to antibiotics 90 days before infection ( p = 0.030), and antibiotic exposure during hospital stay including carbapenems ( p = 0.013), enzyme inhibitors ( p = 0.021), nitroimidazoles ( p = 0.029), and glycopeptides ( p = 0.000). Multivariable analysis showed that sputum suction (odds ratio 3.090, 95% confidence intervals 1.004–9.518, p = 0.049) was an independent risk factor for CRKP infections. Patients infected with CRKP with longer carbapenems treatment course ( p = 0.002) showed better outcome. Conclusion: This study showed the severity of CRKP infection in eastern China. Sputum suction was an independent risk factor for CRKP infection. Prolonged duration of treatment with carbapenems benefited the patients infected with CRKP.
机译:背景:对碳青霉烯类耐药的肺炎克雷伯菌(CRKP)的患病率日益上升,对全世界的治疗构成了直接威胁。这项回顾性研究评估了中国上海一家综合教学医院的分子流行病学并确定了CRKP感染的危险因素和结果。方法:从2013年1月至2015年7月,收集了100例从住院患者中分离出的连续CRKP分离株。通过聚合酶链反应筛选分离株的抗生素抗性基因,并通过脉冲场凝胶电泳(PFGE)进行分子分型。感染CRKP的患者组成病例组,并与感染碳青霉烯易感性肺炎克雷伯菌的患者的对照组进行比较。比较了CRKP感染组的治疗效果。结果:在100个CRKP分离株中,耐多药,广泛耐药(XDR)和耐全药的百分比分别为50.0、50.0和0%。所有CRKP分离株均产生KPC-2,可分为18个PFGE簇(A–O)和70个亚型。使用80%相似性的临界值未检测到主要的医院内PFGE类型。 CRKP感染与定植的比例为51:49。与CRKP感染相关的危险因素包括肺部疾病(p = 0.038),ICU停留时间(p = 0.002),有创通气(p = 0.009),输血(p = 0.028) ,肠胃外营养(p = 0.004),吸痰(p = 0.006),既往住院病史(p = 0.022),感染前90天接触抗生素(p = 0.030)以及住院期间包括碳青霉烯类的抗生素暴露(p = 0.030) p = 0.013),酶抑制剂(p = 0.021),硝基咪唑(p = 0.029)和糖肽(p = 0.000)。多变量分析显示,痰液抽吸(赔率3.090,95%置信区间1.004-9.518,p = 0.049)是CRKP感染的独立危险因素。接受碳青霉烯治疗疗程较长的CRKP感染的患者(p = 0.002)显示出更好的预后。结论:本研究显示了中国东部地区CRKP感染的严重程度。吸痰是CRKP感染的独立危险因素。碳青霉烯类药物治疗时间的延长使感染了CRKP的患者受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号